POMILIO LUKE A 4
4 · CONMED CORP · Filed Feb 5, 2018
Insider Transaction Report
Form 4
CONMED CORPCNMD
POMILIO LUKE A
Vice President & Controller
Transactions
- Exercise/Conversion
Sars (Stock Appreciation Rights)
2018-02-01−18,400→ 27,600 totalExercise: $51.30Exp: 2025-02-27→ Common Stock (18,400 underlying) - Tax Payment
Common Stock
2018-02-01$63.35/sh−16,438$1,041,347→ 1,962 total - Sale
Common Stock
2018-02-01$63.38/sh−18,023$1,142,229→ 0 total - Exercise/Conversion
Common Stock
2018-02-01$51.30/sh+18,400$943,920→ 18,400 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- [F2]The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.